FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/11/076335 [Registered on: 06/11/2024] Trial Registered Prospectively
Last Modified On: 06/10/2024
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   comparision of intravenous ibuprofen versus intravenous paracetamol in Functional Endoscopic Sinus Surgery 
Scientific Title of Study   A Prospective randomized controlled study on comparison of intravenous Ibuprofen and Paracetamol for post operative pain relief in functional endoscopic sinus surgeries (FESS) 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr LGeetha Ramalakshmi 
Designation  post Graduate 
Affiliation  SRM Medical college hospital and research centre 
Address  Room no 1.B block anaesthesia department SRM Medical college hospital and Research Centre SRM nagar, Potheri Chengalpattu district Kanchipuram Tamil Nadu - 603203 India

Kancheepuram
TAMIL NADU
603203
India 
Phone  9944559112  
Fax    
Email  vasanthasaigeetha@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DrR Balaji 
Designation  Professor 
Affiliation  SRM Medical college hospital and research centre 
Address  Room no 1.B block anaesthesia department SRM Medical college hospital and Research Centre SRM nagar, Potheri Chengalpattu district Kanchipuram Tamil Nadu - 603203 India

Kancheepuram
TAMIL NADU
603203
India 
Phone  9677053310  
Fax    
Email  aarbee79@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DrR Balaji 
Designation  Professor 
Affiliation  SRM Medical college hospital and research centre 
Address  Room no 1.B block anaesthesia department SRM Medical college hospital and Research Centre SRM nagar, Potheri Chengalpattu district Kanchipuram Tamil Nadu - 603203 India

Kancheepuram
TAMIL NADU
603203
India 
Phone  9677053310  
Fax    
Email  aarbee79@gmail.com  
 
Source of Monetary or Material Support  
SRM Medical collage Hospital and Research centre,SRM nagar,potheri,chengalpattu district,tamil nadu 603203 
 
Primary Sponsor  
Name  SRM Medical collage Hospital and Research centre 
Address  Room no 5, B block,SRM Medical collage hospital and research centre SRMNAGAR,potheri,chengalpattu district kanchipuram, Tamil Nadu-603203 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrKKarthick  SRM Medical collage Hospital and Research centre  SRM Medical collage Hospital and Research centre kattangulathur 603203
Kancheepuram
TAMIL NADU 
9444586662

karthikk1@srmist.edu.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
SRM Medical College A Hospital And Research Centre  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Group I  Inj.Ibuprofen 400 mg IV is administered 15 min before the end of procedure for FESS and pain intensity is measured using VAS score postoperatively 
Comparator Agent  Group P  Inj.Paracetamol 1 gm IV is administered 15 min before the end of procedure for FESS and pain intensity is measured using VAS score Post operatively 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  ASA 1 and ASA 2 Patients
patient weight between 50 to 80 kg 
 
ExclusionCriteria 
Details  Hepatic disease and renal disorders
History of GERD and peptic ulcer
History of drug allergy
patient with coagulation abnormality 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Duration of Post operative analgesia  assessment of VAS score at 0hour,4hours,8hours,12hours, 16hours,20hours and 24 hours, 
 
Secondary Outcome  
Outcome  TimePoints 
VAS score during first 24 hrs of postoperative period
Total amount of NSAID used
Total amount of rescue analgesic used
 
0 to 24 hrs after the end of procedure 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   14/11/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study will be performed in patients scheduled to undergo FESS surgery under general anesthesia. A written informed consent will be obtained from the participants. The participants will be allocated into two groups by computer-generated random numbers group I is Ibuprofen and group P is paracetamol. Anaesthesia premedication and induction will be standardized among two groups. The surgeon will be asked to infiltrate with plain adrenaline not xylocaine with adrenaline for local site infiltration. ibuprofen 400mg and paracetamol 1gm will be administered in the respective groups 15 min before the end of the procedure and patient will be shifted to post anaesthesia care unit and pain intensity will be monitored using VAS score for 24 hrs. if the VAS score >4 ibuprofen and paracetamol will be repeated in the respective groups and inj.tramadol 100mg iv will be administered if needed as a second rescure analgesic.

 
Close